Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingyang Su
Observed names:
Jing-Yang Su,
Jing-yang Su
Institutions:
Zhejiang Chinese Medical University,
Tongde Hospital of Zhejiang Province
Observed institutions:
Zhejiang Chinese Medical University,
Tongde Hospital of Zhejiang Province,
Hangzhou Hospital of Traditional Chinese Medicine,
Tianjin Medical University,
China Medical University
ORCID:
0000-0001-5592-7055
Observed ORCID:
0000-0001-5592-7055
OpenAlex ID:
A5019260633
Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
2022
·
Ming Xu
, Jin-hua Lu
, et al.
·
Frontiers in Oncology
·
72
Jiawei Maxing Shigan Tang alleviates radiation-induced lung injury via TGF-β1/Smad signaling pathway mediated by regulatory T cells
2023
·
Menglei Wang
, Yuqian Feng
, et al.
·
Journal of Ethnopharmacology
·
25
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?
2022
·
Jingyang Su
, Jinhua Lu
, et al.
·
Current Opinion in Oncology
·
13
Efficacy and safety of IDH inhibitors in IDH-mutated cancers: a systematic review and meta-analysis of 4 randomized controlled trials
2024
·
Zelin Cai
, Huiting Yang
, et al.
·
World Journal of Surgical Oncology
·
12
PDF
Efficacy and safety of multi-kinase inhibitors in patients with radioiodine-refractory differentiated thyroid cancer: a systematic review and meta-analysis of clinical trials
2022
·
Jingyang Su
, Menglei Wang
, et al.
·
Expert Review of Anticancer Therapy
·
12
Efficacy and safety of trastuzumab deruxtecan in patients with solid tumors: a systematic review and meta-analysis of 3 randomized controlled trials.
2023
·
Ze-Lin Cai
, Hui-Ting Yang
, et al.
·
PubMed Central
·
10
PDF
PPM1A as a key target of the application of Jiawei‑Maxing‑Shigan decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells
2021
·
Jinhua Lu
, Shengyou Lin
, et al.
·
Molecular Medicine Reports
·
9
PDF
Association of anxiety disorder, depression, and bipolar disorder with autoimmune thyroiditis: A bidirectional two-sample mendelian randomized study
2024
·
Jingyang Su
, Jialin Zhang
, et al.
·
Journal of Affective Disorders
·
7
A meta-analysis and systematic review of the first Trop-2-targeting antibody–drug conjugate (sacituzumab govitecan) in treating metastatic breast cancer
2025
·
Jue Wang
, Shengyou Lin
, et al.
·
European Journal of Clinical Pharmacology
·
6
A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
2025
·
Jialin Zhang
, Xinyu Xu
, et al.
·
Frontiers in Oncology
·
6
Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
2024
·
Jingyang Su
, Jialin Zhang
, et al.
·
Frontiers in Pharmacology
·
6
Efficacy and safety of dorzagliatin, a novel glucokinase activators, in the treatment of T2DM: A meta-analysis of randomized controlled trials
2024
·
Yuqian Wu
, Kai Wang
, et al.
·
Medicine
·
6
Guilu erxian glue alleviates chemotherapy-induced myelosuppression by regulating histone methylation level of p16 gene in hematopoietic stem cells
2025
·
Menglei Wang
, Jue Wang
, et al.
·
Clinical Traditional Medicine and Pharmacology
·
5
Effect of vegetable consumption on risk of gastric cancer: a systematic review and multi-level meta-analysis of prospective studies
2024
·
Xiaomin Wu
, Guoqiang Qin
, et al.
·
Nutrition Research Reviews
·
4
Recent advances and applications of semiconducting polymer nanomaterials in cancer therapy
2025
·
Yifang Liu
, Jingyang Su
, et al.
·
Precision medicine and engineering.
·
3
Evaluating the efficacy and safety of trebananib in treating ovarian cancer and non-ovarian cancer patients: a meta-analysis and systematic review
2024
·
Jialin Zhang
, Jingyang Su
, et al.
·
Expert Review of Anticancer Therapy
·
3
Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches
2024
·
Jing Jiang
, Jinhua Lu
, et al.
·
Combinatorial Chemistry & High Throughput Screening
·
3
Efficacy and safety of HER2-targeted therapy in patients with colorectal cancer: What should we expect from a meta-analysis?
2023
·
Menglei Wang
, Jingyang Su
, et al.
·
Clinics and Research in Hepatology and Gastroenterology
·
3
Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysis
2024
·
Jialin Zhang
, Jingyang Su
, et al.
·
Future Oncology
·
2
Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysis
2024
·
Jingyang Su
, Cui Ni
, et al.
·
Expert Review of Anticancer Therapy
·
2
The pathogenesis and treatment differences between differentiated thyroid carcinoma and medullary thyroid carcinoma
2022
·
Jingyang Su
, Yue Fu
, et al.
·
Current Medical Research and Opinion
·
2
PDF
Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation
2024
·
Jing-Yang Su
·
American Journal of Cancer Research
·
1
PDF
Efficacy and safety of third-generation EGFR-TKIs in patients with non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials
2023
·
Zelin Cai
, Huiting Yang
, et al.
·
Research Square
·
1
PDF
[Retracted] PPM1A as a key target of the application of Jiawei‑Maxing‑Shigan decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells
2026
·
Jinhua Lu
, Shengyou Lin
, et al.
·
Molecular Medicine Reports
PDF
Exploring the Association Between Mental Disorders and Various Arrhythmias via Mendelian Randomization Methods
2026
·
Jingyang Su
, Jialin Zhang
, et al.
·
Genes Brain & Behavior
Show more works
View as search
Works count:
27
Citation count:
213
H-index:
7
I10-index:
6
Year
Topic
Type